Showing results (81-90 of 292) with videos related to

Sort By:
Pageof 30
Drugs|January 1, 1989
Profile of an ideal antianginal agentE J Lazar, W H Frishman
American Heart Journal|September 1, 1995
Endothelin and endothelin antagonism: roles in cardiovascular health and diseaseP Tamirisa, W H Frishman, A Kumar
American Heart Journal|February 1, 1995
Controlled-release drug delivery systems in cardiovascular medicineB Katz, A Rosenberg, W H Frishman
Cardiology Clinics|November 1, 1987
Beta-adrenergic blockade in childrenA Kornbluth, W H Frishman, M Ackerman
The Medical Clinics of North America|March 1, 1988
Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertensionW H Frishman, G Eisen, J Lapsker
The Medical Clinics of North America|March 1, 1988
Serotonin antagonism in the treatment of systemic hypertension: the role of ketanserinW H Frishman, S Okin, S Huberfeld
Journal of Clinical Pharmacology|January 1, 1991
Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteinsP Zimetbaum, W H Frishman, S Kahn
American Journal of Therapeutics|July 29, 1999
Testosterone and other anabolic steroids as cardiovascular drugsJ Shapiro, J Christiana, W H Frishman
Postgraduate Medicine|December 1, 1985
Use of beta-adrenergic blocking agents after myocardial infarctionW H Frishman, J Ruggio, C Furberg
The Medical Clinics of North America|March 1, 1989
Angiotensin-converting enzyme inhibitors in heart failureM Borek, S Charlap, W H Frishman
Pageof 30